UBA52P9

Across TCGA pan-cancer cohorts, UBA52P9 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated UBA52P9 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher UBA52P9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated UBA52P9 expression acts as an unfavorable survival marker, although some lineages such as BRCA show a favorable association.

LUAD, STAD, and LIHC are the cancer types where UBA52P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	III,IV	0.147	0.679	.001	36	view →
STAD	OS	Tertile	II,III,IV	0.191	0.580	.011	18	view →
LIHC	OS	Tertile	All	0.013	0.784	<.001	18	view →
READ	OS	Tertile	IV	0.077	1.000	.014	18	view →
BRCA	DFS	Tertile	II,III,IV	1.000	0.500	.041	12	view →
SKCM	OS	Tertile	IV	0.247	0.721	.038	9	view →
PCPG	OS	Tertile	All	0.571	0.963	<.001	9	view →
KIRC	OS	Tertile	All	0.348	0.636	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

UBA52P9–LUAD (OS)

Open the LUAD breakdown →